Beam Therapeutics Inc.
BEAM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,489 | $1,735 | $1,718 | $2,054 |
| - Cash | $268 | $282 | $528 | $282 |
| + Debt | $151 | $155 | $158 | $161 |
| Enterprise Value | $2,373 | $1,608 | $1,348 | $1,933 |
| Revenue | $10 | $8 | $7 | $30 |
| % Growth | 14.6% | 13.3% | -75.2% | – |
| Gross Profit | -$100 | -$93 | -$91 | -$71 |
| % Margin | -1,031.9% | -1,102% | -1,222.8% | -237.4% |
| EBITDA | -$107 | -$115 | -$114 | -$95 |
| % Margin | -1,105.1% | -1,353.8% | -1,522.9% | -314.6% |
| Net Income | -$113 | -$102 | -$109 | -$90 |
| % Margin | -1,162.4% | -1,208.3% | -1,462.8% | -300.5% |
| EPS Diluted | -1.1 | -1 | -1.24 | -1.09 |
| % Growth | -10% | 19.4% | -13.8% | – |
| Operating Cash Flow | -$81 | -$76 | -$104 | -$76 |
| Capital Expenditures | -$5 | -$3 | -$3 | -$3 |
| Free Cash Flow | -$86 | -$80 | -$107 | -$79 |